Anatomical and Systemic Risk Factors for Recurrence in Medication-Related Osteonecrosis of the Jaw (MRONJ): A Retrospective Study of 812 Patients. [PDF]
Park KC, Kim HJ, Oh JS, Moon SY.
europepmc +1 more source
Calcium Phosphate Bone Substitutes in the Prevention of Bisphosphonate-Related Osteonecrosis of the Jaw: A Review. [PDF]
Paulo S +8 more
europepmc +1 more source
Incidental Mandibular FDG Uptake on PET/CT Preceding Medication-Related Osteonecrosis of the Jaw in a Patient Receiving High-Dose Denosumab: A Case Report. [PDF]
Sakamoto Y, Sawada S, Umeda M, Kojima Y.
europepmc +1 more source
Possible Contribution of Oral Microbiota in the Osteonecrosis of the Jaw Induced by Zoledronate or Denosumab: A Preliminary Study. [PDF]
Erovigni FM +13 more
europepmc +1 more source
Synergistic application of concentrated growth factor and bone perforation technique in bisphosphonate-related-osteonecrosis of the jaw. [PDF]
Sun J +5 more
europepmc +1 more source
Association between periodontal disease severity and the risk of medication-related osteonecrosis of the jaw: a systematic review and meta-analysis by the Korean Academy of Periodontology. [PDF]
Lee JH +6 more
europepmc +1 more source
Identifying the clinical indicator for surgical intervention in medication-related osteonecrosis of the jaw. [PDF]
Tadokoro Y +7 more
europepmc +1 more source
Asia-Pacific consensus statement on medication-related osteonecrosis of the jaw in patients with osteoporosis. [PDF]
Taguchi A +31 more
europepmc +1 more source
Medication-related osteonecrosis of the jaw in breast cancer patients: a longitudinal observational Swedish study of oral health and antiresorptive use. [PDF]
Korytowska M +4 more
europepmc +1 more source

